Investor Letters

O'Keefe Stevens Advisory

okeefestevens.com

Quarterly Investor Letter Q2 2026 O'Keefe Stevens Advisory initiated Sotera Health after Warburg Pincus exited, arguing that its sterilization duopoly, regulatory barriers and normalizing capital spending can outweigh litigation concerns. The portfolio trimmed and hedged Qualcomm and Corning, retained substantial cash, and sees potential bargains outside crowded AI infrastructure trades. Q2 2026 SHC $5.6BCALY $2.8BGLW $131BHCC $5.6B
Quarterly Investor Letter Q1 2026 O'Keefe Stevens Advisory built cash after selling Alibaba, Fannie Mae common, Mercedes-Benz and Tri Pointe Homes, while initiating Baxter and adding to Perrigo and Weyerhaeuser. The firm argues that elevated AI-related spending and stretched valuations warrant selective underwriting, with Baxter’s deleveraging and Perrigo’s restructuring offering security-specific catalysts. Q1 2026 BAX $14BPRGO $1.9BBABA $290BCALY $2.8B
Quarterly Investor Letter Q4 2025 O'Keefe Stevens sold Fannie Mae common shares after conservatorship-exit expectations changed the risk-reward profile, while retaining preferred securities tied to eventual privatization. The firm added to Callaway after its Topgolf stake sale, trimmed Sphere despite its expanding venue and content opportunity, and sees a lumber-market recovery supporting GreenFirst. Q4 2025 FNMA $7.3BICLTF $35MMODG delistedSPHR $5.6B
Quarterly Investor Letter Q3 2025 O'Keefe Stevens Advisory warns that AI-related capital spending and crypto speculation require valuation discipline, using Corning’s dot-com history to frame the risk. The portfolio exited Donnelley Financial, Lazard and Capstone Copper, initiated Topgolf Callaway Brands, and retained Compass Minerals after a Goderich mine visit. Q3 2025 GLW $131BCMP $1BCSCCY $13BDFIN $1.2B